SMITH ASSET MANAGEMENT GROUP LP - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 209 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2013$588,000
-6.4%
73,727
-9.3%
0.02%
-11.1%
Q2 2013$628,000–81,327–0.03%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders